Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 2Lymphoid 2Genitourinary 2Gastrointestinal 2Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1Endocrine 1Breast 1

Conditions

Oral Complications 1

Interventions

Cisplatin 42Pemetrexed 31Carboplatin 28Nivolumab 21pembrolizumab 19Gemcitabine 19atezolizumab 13Etoposide 13Injections 12Ipilimumab 11Cyclophosphamide 11Radiotherapy 10Oxaliplatin 10Filgrastim 10Docetaxel 10Bevacizumab 10tislelizumab 9Vincristine 9Specimen Handling 9durvalumab 8Paclitaxel 8Capecitabine 8tremelimumab 7toripalimab 7lenvatinib 7Everolimus 7spartalizumab 6olaparib 6niraparib 6Vinorelbine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Glutamine × Other solid neoplasm × Clear all
NCT00003898 2011-03-01

Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation

Roswell Park Cancer Institute

Phase 2 Completed
120 enrolled
Other solid neoplasm

Oral Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡